euro-pathology-hematologic-oncology-2018-keynote

6 / 10

Volume 8 Journal of Clinical & Experimental Pathology
ISSN : 2161-0681 Euro Pathology 2018 | Hematologic Oncology 2018
June 20-21, 2018
Page 27
Notes:
conferenceseries.com
15 th EUROPEAN PATHOLOGY CONGRESS
&
LEUKEMIA AND HEMATOLOGIC ONCOLOGY
June 20-21, 2018 | Paris, France
14th International Conference on
JOINT EVENT
Yener Koc, J Clin Exp Pathol 2018, Volume 8
DOI: 10.4172/2161-0681-C1-044
Toxicity, drug interactions & follow-up in hematopoietic stem cell transplantation
To establish andmaintain high cure rates and lowmortality in the area of hematopoietic stem cell transplantation, accesibility
and availability of well-trained experts capable of interpretation of toxicity and drug interactions at 24/7 hours basis and
prompt management side-effects is absolutely necessary, besides trained nurses understanding pathophysiology and clinical
signs of transplant complications including graft versus host disease (GVHD), a man-made disease, threatening patients
survival and quality of life which may last months or years. Recently, an independent varible called ‘center effect’ is being stated
in international transplant meetings, corresponding to transplant center’s expertise and ability that may lead to higher post-
transplant survival rates above the world average. JACIE accredited transplant centers have also been shown to be associated
with lower mortality and higher survival rates as satted in EBMT publications. Management of transplant complications
including drug toxicity and interactions play a key role in patient outcome and development of expertise in this area requires
intense training at a successful transplant center and dedication of skillfull attendings to management of transplant patients.
Biography
Yener Koc completed Hematology training at Boston University followed by Bone Marrow Transplant training between 1996-1999 at New England Medical Center, USA.
He was given Outstanding Physician Award, twice at Boston University. He performed more than 1700 transplants in 24 years at centers accredited by European and
International Transplant Registries (EBMT, CIBMTR) with low transplant mortality and cure rates above world average, including haploidentical allogeneic transplants. He
has numerous publications in peer reviewed journals on 84 research items with 1347 citations over the past 33 years. He is working as JACIE accreditation inspector in
EBMT since 2004.
Yener Koc
Antalya Medicalpark Hospitals, Turkey